Loading clinical trials...
Loading clinical trials...
Efficacy of Adjuvant Chemotherapy in Patients With Clinical Stage III Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy: A Pathology-oriented, Prospective, Multicenter, Randomized, Open-label, Parallel Group Clinical Trial
Conditions
Interventions
Capecitabine
mFOLFOX6 or CAPOX
Locations
1
China
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
Start Date
November 5, 2018
Primary Completion Date
December 1, 2020
Completion Date
December 1, 2025
Last Updated
November 6, 2018
NCT06662786
NCT06663319
NCT05239741
NCT07154173
NCT05770102
NCT04812912
Lead Sponsor
LI XIN-XIANG
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions